Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Minerva Neurosciences Inc increased its cash reserves by 13.31%, or 4.82m. Cash Flow from Financing totalled 19.60m or -- of revenues. In addition the company used 14.78m for operations while cash from investing was breakeven.
Cash flow per share | -0.4335 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -3.10 |
---|---|
Tangible book value per share | -5.22 |
More ▼
Balance sheet in USDView more
Current ratio | 6.23 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼